Relief Therapeutics Holding SA announced that Nermeen Varawalla, M.D., Ph.D., chief medical officer, will depart the Company in the second quarter of 2023 to pursue other opportunities. The medical affairs team will report to Paolo Galfetti, chief operating officer at Relief Therapeutics, until a replacement is hired. Clinical development and regulatory responsibilities will continue to be supported by consultants already contracted with the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.293 CHF | +1.02% | +4.92% | -35.68% |
May. 08 | Relief Therapeutics Restructures Management Team, Creates New Roles | MT |
May. 08 | Relief Therapeutics Announces Executive Changes | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.68% | 17.77M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- RLF Stock
- News Relief Therapeutics Holding SA
- Relief Therapeutics Holding SA Announces Executive Changes